Definigen

About Definigen

DefiniGEN specializes in providing optimized human cell products to the scientific community, focusing on drug discovery and regenerative medicine applications. The company leverages its expertise in generating induced pluripotent stem cell (iPSC) derived hepatocyte disease models and a wide array of bespoke bioassays. DefiniGEN collaborates closely with research teams to design and implement in-house screening of small molecules and advanced genetic therapies, enabling faster advancement of scientific programs. The company offers a diverse panel of iPSC lines, allowing for disease models and cell-based bioassays from donors of varying gender, age, and ethnicity. DefiniGEN primarily serves pharmaceutical companies, biotech firms, and academic research institutions. The business model revolves around providing tailored disease modeling products and services, generating revenue through the sale of these specialized cell products and bioassays.